Executive Summary
Across these 6 filings, a dominant theme is the ramp-up to FY26 earnings season with multiple board meetings scheduled (Tata Motors May 13, IDBI Bank Apr 30, Bondada already approved results), signaling imminent financial disclosures amid closed trading windows. Period-over-period trends show mixed revenue performance: Carnot Technologies (Mahindra sub) revenue declined 14.2% YoY FY26 (Rs.19.80cr vs Rs.23.08cr FY25) and 20.2% from FY24 (Rs.24.81cr), contrasting Infosys' modest FY26 +3.1% CC growth and Q4 +4.1% YoY CC, with employee headcount down 8,000 over 5-6 quarters. Forward-looking highlights include Infosys FY27 guidance of 1.5-3.5% YoY CC revenue (margins 20-22%) amid AI productivity pressures, and Apollo's NCLT-approved scheme meetings in May 2026 accelerating restructuring. No insider trading or delisting signals, but capital allocation focus on dividends (Tata Motors) and related-party acquisitions (Mahindra). Portfolio-level: Auto/Engineering firms prepping results positively, IT guidance cautious, healthcare scheme bullish; watch for margin resilience and guidance beats amid competitive headwinds.
Tracking the trend? Catch up on the prior India BSE NSE Trading Suspension Orders digest from April 18, 2026.
Investment Signals(11)
- Mahindra & Mahindra↓(BULLISH)▲
Acquired 28.03% additional stake in Carnot at Rs.11,978/share for Rs.6.72cr, boosting equity to 80.72%/voting 89%, aligning with precision farming strategy despite Carnot's FY26 revenue -14.2% YoY
- Apollo Hospitals↓(BULLISH)▲
NCLT Chennai approved dispensation of secured creditors' meeting (90.96% consent) and rescheduled equity/unsecured meetings to May 21-27, 2026, fast-tracking composite scheme with Apollo Healthco/Keimed/Healthtech
- Tata Motors↓(NEUTRAL-BULLISH)▲
Board meeting May 13, 2026 for Q4/FY26 audited results, dividend recommendation, and analyst call; trading window closed since Mar 25 until 48hrs post-results
- Infosys↓(BULLISH)▲
FY26 revenue +3.1% CC (Q4 +4.1% YoY CC) driven by Financial Services/Communications/Manufacturing/Europe, large deals $14.9B (+28% YoY), AI services >5.5% of Q4 revenue
- Bondada Engineering↓(BULLISH)▲
Board approved Q4/FY26 audited standalone/consolidated results Apr 27 with unmodified auditor opinion (M/s. Sreedar Mohan & Associates), disclosures on www.bondada.net
- IDBI Bank↓(NEUTRAL)▲
Board meeting Apr 30, 2026 for Q4/FY26 audited results under SEBI LODR Reg 29/50; trading window closed until May 2
- Infosys↓(BULLISH)▲
FY26 margins resilient at 21% despite 1% drag from third-party revenue and 70bps on-site mix; Q4 headwinds offset by 40bps currency/30bps Maximus
- Mahindra & Mahindra↓(NEUTRAL-BULLISH)▲
Carnot FY26 PAT Rs.1.17cr and net worth Rs.6cr on arm's-length related-party deal, completion May 2026, no Debt-to-Equity spike implied
- Apollo Hospitals↓(BULLISH)▲
Scheme progression under Sections 230-232 Companies Act avoids prior creditor meeting, new dates enhance timeline certainty vs original May 16-17
- Bondada Engineering↓(BULLISH)▲
Unmodified audit opinion on FY26 results contrasts potential sector peers' qualifications, board met Apr 27 (6:30-8:45 PM)
- Infosys↓(MILD BULLISH)▲
Stratus acquisition closed (+25bps FY27 guidance), Optimum/Australian JV pending approvals
Risk Flags(8)
- Mahindra & Mahindra/Carnot Sub↓[MEDIUM RISK]▼
Revenue declined 14.2% YoY FY26 (Rs.19.80cr vs Rs.23.08cr FY25) and 20.2% from FY24 (Rs.24.81cr), signaling operational weakness in precision farming/telematics
- Infosys/Guidance↓[HIGH RISK]▼
FY27 revenue guidance modest 1.5-3.5% YoY CC amid competitive intensity, AI productivity impacts, client spending compression
- Infosys/Workforce↓[MEDIUM RISK]▼
Employee count declined >8,000 in last 5-6 quarters, potential utilization/margin pressure despite AI growth
- Infosys/Margins↓[MEDIUM RISK]▼
FY26 21% margins faced Q4 headwinds (50bps acquisition amortization, 20bps comp), FY27 guided 20-22%
- Tata Motors/Trading Window↓[LOW-MEDIUM RISK]▼
Closure from Mar 25, 2026 until 48hrs post-May 13 results limits insider activity visibility, potential for surprises
- IDBI Bank/Trading Window↓[LOW RISK]▼
Closure until May 2, 2026 post-Apr 30 results, watch for deposit/NIM trends in banking sector
- Mahindra & Mahindra/Related Party↓[LOW-MEDIUM RISK]▼
Acquisition from existing shareholders at Rs.11,978/share, mixed sentiment on declining sub revenue
- Infosys/Acquisitions↓[LOW RISK]▼
Optimum/Australian JV pending regulatory approvals, not in FY27 guidance, execution risk
Opportunities(8)
- Apollo Hospitals/NCLT Scheme↓(OPPORTUNITY)◆
Accelerated meetings (secured May 27, equity May 27, unsecured May 21/26) post-90.96% consent, potential value unlock in Healthco/Keimed/Healthtech integration
- Bondada Engineering/Results Release↓(OPPORTUNITY)◆
Fresh unmodified FY26 audited results approval, available on website; relative outperformance vs peers with qualified opinions
- Tata Motors/Earnings Catalyst↓(OPPORTUNITY)◆
May 13 board for Q4/FY26 results + dividend, analyst call same day; potential beat on auto recovery
- Infosys/AI Pivot↓(OPPORTUNITY)◆
AI services >5.5% Q4 revenue (up from Q3), large deals $3.2B Q4/$14.9B FY (+28% YoY), margin resilience at 21%
- Mahindra & Mahindra/Subsidiary Control↓(OPPORTUNITY)◆
80.72% equity/89% voting in Carnot post-Rs.6.72cr acquisition, strategic telematics exposure despite revenue dip
- IDBI Bank/Imminent Results↓(OPPORTUNITY)◆
Apr 30 board for FY26 results, early banking disclosure vs peers; watch NIM/asset quality
- Infosys/Deal Momentum↓(OPPORTUNITY)◆
$14.9B TCV FY26 (+28% YoY) across BFSI/Communications, Stratus closed adding 25bps to FY27
- Apollo Hospitals/Timeline Certainty↓(OPPORTUNITY)◆
Modified dates from original May 16-17 provide clarity, positive sentiment on scheme completion
Sector Themes(6)
- Upcoming Earnings Density - Auto/Engineering/Banking◆
4/6 filings (Tata Motors May 13, IDBI Apr 30, Bondada approved Apr 27) signal FY26 results wave; unmodified opinions (Bondada) vs potential qualifications elsewhere imply sector resilience [IMPLICATION: Position for beats, trading windows closed limit front-running]
- Modest IT Growth with AI Tailwinds◆
Infosys FY26 +3.1% CC revenue (Q4 +4.1% YoY), but FY27 1.5-3.5% guidance amid headcount cuts (-8k/5-6qtrs); AI >5.5% Q4 revenue contrasts margin drags [IMPLICATION: Cautious longs on deal wins vs productivity risks]
- Healthcare Restructuring Momentum◆
Apollo's NCLT approval (90.96% consent) reschedules May meetings, positive sentiment vs mixed elsewhere [IMPLICATION: Consolidation alpha in hospitals post-scheme]
- Subsidiary Investments Amid Declines◆
Mahindra's Rs.6.72cr for 28% Carnot stake despite -14.2% YoY revenue; related-party arm's-length [IMPLICATION: Parent conviction in agrotech despite sub weakness]
- Capital Allocation via Dividends/Results◆
Tata Motors/IDBI to consider dividends post-results; no buybacks/splits noted [IMPLICATION: Yield focus in uncertain growth environment]
- Resilient Audit Outcomes◆
Bondada unmodified opinion; no red flags in disclosures across filings [IMPLICATION: Lower governance risk in small/midcaps]
Watch List(7)
Q4/FY26 results, dividend recommendation, analyst call on May 13, 2026; trading window reopens 48hrs post [MONITOR FOR BEATS/DIVIDEND]
Audited Q4/FY26 results on Apr 30, 2026; trading window closed until May 2 [MONITOR NIM/ASSET QUALITY]
- Apollo Hospitals/Shareholder Meetings↓(MONITOR SCHEME APPROVAL)👁
Equity May 27 (2:30PM), secured creditors May 27 (10AM), unsecured May 21/26, 2026
Guidance 1.5-3.5% CC revenue, 20-22% margins; track Optimum/JV approvals, AI revenue share [MONITOR Q1 FY27]
Carnot stake completion May 2026 post-Apr 27 transaction [MONITOR INTEGRATION/SYNERGIES]
Full FY26 standalone/consolidated on www.bondada.net post-Apr 27 approval [MONITOR METRICS/OUTLOOK]
- Infosys/Headcount Trends↓(MONITOR MARGIN IMPACT)👁
>8,000 decline in 5-6 quarters; watch utilization in earnings calls
Filing Analyses(6)
27-04-2026
Mahindra & Mahindra Ltd has acquired an additional 28.03% stake in its subsidiary Carnot Technologies Private Limited for Rs. 6.72 crore, increasing its equity holding to 80.72% and voting rights to 89%, aligning with its strategy in precision farming and telematics. Carnot reported FY26 revenue of Rs. 19.80 crore, marking a decline from Rs. 23.08 crore in FY25 and Rs. 24.81 crore in FY24, alongside PAT of Rs. 1.17 crore and net worth of Rs. 6.00 crore. The transaction is a related party deal on arm's length basis, with completion expected in May 2026.
- ·Share purchase price: Rs.11,978 per share
- ·Carnot date of incorporation: 24th August 2015
- ·Transaction executed on April 27, 2026 at 06:11 p.m., indicative completion: May 2026
- ·No governmental or regulatory approvals required
27-04-2026
Apollo Hospitals Enterprise Limited received the certified true copy of the NCLT Chennai order dated April 15, 2026, on April 27, 2026, approving dispensation of the secured creditors' meeting for the composite scheme of arrangement due to 90.96% consent via affidavit, avoiding the previously ordered meeting. The order also modifies and approves new dates for equity shareholders' meeting (27th May 2026, 2:30 PM), unsecured creditors' meetings (21st May 2026, 11:00 AM for Company 1; 26th May 2026, 3:00 PM for Company 3 at specified venue), and secured creditors' meeting (27th May 2026, 10:00 AM). This progresses the scheme involving Apollo Healthco Limited, Keimed Private Limited, and Apollo Healthtech Limited under Sections 230-232 of the Companies Act, 2013.
- ·NCLT application numbers: CA/CAA/8/CHE/2026, IA(CA)/99/CHE/2026, IA(CA)/100/CHE/2026, IA(CA)/101/CHE/2026
- ·Original meeting dates modified from 16th May 2026 and 17th May 2026
- ·Unsecured creditors meeting for Company 3 at Paragon Towers, Plot No. 9 & 10, Rukmani Colony, Nehru Nagar, 1st Street, Kottivakkam, Chennai
27-04-2026
Tata Motors Limited has scheduled a Board of Directors meeting on May 13, 2026, to consider and approve the audited standalone and consolidated financial results for the fourth quarter and financial year ended March 31, 2026, along with auditors' reports. The board will also recommend a dividend declaration, if any, for shareholder approval at the forthcoming 2nd Annual General Meeting. The trading window for designated persons remains closed from March 25, 2026, until 48 hours after the financial results publication, with an analyst/investors' call planned on the announcement day.
- ·Trading Window closure: March 25, 2026, to 48 hours post-publication of financial results.
- ·Analyst/Investors’ call to be hosted on www.cv.tatamotors.com on the day of financial results announcement.
- ·Intimation under Regulations 29(1)(a), 50(1)(c), and 30 of SEBI Listing Regulations.
27-04-2026
Infosys delivered FY26 revenue growth of 3.1% in constant currency terms, with Q4 growth at 4.1% YoY CC, supported by strong performance in Financial Services, Communications, Manufacturing, and Europe, alongside large deals of $14.9B for the year (28% YoY increase) and $3.2B in Q4. AI services revenue grew beyond 5.5% of total revenue in Q4 from Q3 levels. However, FY27 revenue guidance is modest at 1.5% to 3.5% YoY CC amid competitive intensity, AI productivity impacts, and client spending compression, with operating margins guided at 20% to 22%; FY26 margins were resilient at 21% despite headwinds like 1% drag from lower third-party revenue and 70 bps from on-site mix.
- ·Employee count declined by over 8,000 in the last five to six quarters.
- ·Stratus acquisition closed and contributes 25 basis points to FY27 guidance; Optimum and Australian JV pending regulatory approvals, not yet included.
- ·Q4 margin headwinds: 50 bps from acquisition amortization, 20 bps from comp, partially offset by 40 bps currency benefit and 30 bps from Maximus.
- ·AI total addressable market estimated at $300-400B by 2030.
- ·Net new large deals at 55% for FY26.
27-04-2026
The Board of Directors of Bondada Engineering Limited met on April 27, 2026, and approved the Audited Standalone and Consolidated Financial Results for Q4 FY 2025-26 and the full financial year ended March 31, 2026. The statutory auditors, M/s. Sreedar Mohan & Associates, issued an unmodified opinion on both standalone and consolidated results. The disclosures will be available on the company's website at www.bondada.net.
- ·Board meeting held from 06:30 PM to 08:45 PM at C-26, Kushaiguda Industrial Area, ECIL, Hyderabad, Telangana 500062.
- ·CIN: L28910TG2012PLC080018
- ·Scrip Code: 543971
27-04-2026
IDBI Bank Limited announced that a Board of Directors meeting will be held on April 30, 2026, to consider and approve the Audited Financial Results for the quarter and year ended March 31, 2026, in compliance with SEBI (LODR) Regulations. The Trading Window for dealing in the Bank's securities by designated persons and their immediate relatives will remain closed until May 02, 2026, per the Bank's Code of Conduct and SEBI (Prohibition of Insider Trading) Regulations.
- ·Filing reference to Regulations 29 and 50 of SEBI (LODR) Regulations, 2015.
- ·Regd. Office: IDBI Tower, WTC Complex, Cuffe Parade, Mumbai - 400 005.
- ·CIN: L65190MH2004G01148838.
Get daily alerts with 11 investment signals, 8 risk alerts, 8 opportunities and full AI analysis of all 6 filings
More from: India BSE NSE Trading Suspension Orders
🇮🇳 More from India
View all →April 20, 2026
India Pre-Market Regulatory Roundup — April 20, 2026
India Pre-Market Regulatory Roundup
April 20, 2026
India Quarterly Results BSE NSE Announcements — April 20, 2026
India Quarterly Results BSE NSE Announcements
April 20, 2026
India Upcoming Corporate Actions BSE NSE — April 20, 2026
India Upcoming Corporate Actions BSE NSE
April 20, 2026
BSE FMCG Sector Regulatory Filings — April 20, 2026
BSE FMCG Sector Regulatory Filings